Sugentech Overview

  • Year Founded
  • 2011

Year Founded

  • Status
  • Public

  • Employees
  • 154

Employees

  • Stock Symbol
  • 253840

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $2.91
  • (As of Wednesday Closing)

Sugentech General Information

Description

Sugentech Inc is an in-vitro diagnostic company. It is developing and selling products that can diagnose many types of diseases based on various platforms such as self-diagnostics home testing products (Self-testing) and Point-of-care testing(POCT) products.

Contact Information

Formerly Known As
Accugen Healthcare
Ownership Status
Publicly Held
Financing Status
Formerly VC-backed
Corporate Office
  • 206, Techno 2-ro
  • Yuseong-gu
  • Daejeon
  • South Korea
+82
Primary Industry
Diagnostic Equipment
Other Industries
Biotechnology
Drug Discovery
Stock Exchange
KRX
Corporate Office
  • 206, Techno 2-ro
  • Yuseong-gu
  • Daejeon
  • South Korea
+82

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Sugentech Stock Performance

As of 18-Nov-2026, Sugentech’s stock price is $2.91. Its current market cap is $44.5M with 15.3M shares.

(As of Wednesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$2.91 $2.82 $2.28 - $5.57 $44.5M 15.3M 348K -$1.04

Sugentech Financials Summary

As of 30-Jun-2026, Sugentech has a trailing 12-month revenue of $6.74M.

In Thousands,
USD
TTM 30-Jun-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 21,224 38,284 25,574 44,412
Revenue 6,742 6,617 7,400 5,455
EBITDA (14,633) (14,862) (13,267) (12,059)
Net Income (15,851) (16,382) (11,135) (13,185)
Total Assets 56,563 68,203 73,077 103,352
Total Debt 9,605 10,042 3,425 11,770
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Sugentech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Sugentech‘s full profile, request access.

Request a free trial

Sugentech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Sugentech Inc is an in-vitro diagnostic company. It is developing and selling products that can diagnose many types of d
Diagnostic Equipment
Daejeon, South Korea
154 As of 2025

Louvain-La-Neuve, Belgium
 

Lexington, MA
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Sugentech Competitors (15)

One of Sugentech’s 15 competitors is Ion Beam Applications, a Corporation company based in Louvain-La-Neuve, Belgium.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Ion Beam Applications Corporation Louvain-La-Neuve, Belgium
Agenus Formerly VC-backed Lexington, MA
Arcus Biosciences Formerly VC-backed Hayward, CA
TRACON Pharmaceuticals Formerly VC-backed San Diego, CA
Fate Therapeutics Formerly VC-backed San Diego, CA
You’re viewing 5 of 15 competitors. Get the full list »

Sugentech Patents

Sugentech Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2026216720-A1 Urine test strip, urine test device comprising same, and urine test method Pending 07-Apr-2025
WO-2025135422-A1 Multi-channel molecular diagnostic cartridge Inactive 18-Dec-2023
WO-2024117597-A1 Detection sensor and detection system for analyte in urine Inactive 28-Nov-2022
US-20250060305-A1 Integrated optical measurement device Pending 04-Oct-2022
WO-2024075934-A1 Integrated optical measurement device Inactive 04-Oct-2022 G01N21/77
To view Sugentech’s complete patent history, request access »

Sugentech Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sugentech Investments & Acquisitions (3)

Sugentech’s most recent deal was a Later Stage VC with Promedigen for . The deal was made on 01-Dec-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Promedigen 01-Dec-2024 Later Stage VC Drug Discovery
Zhuhai Nakbok Photo Technology 29-Jun-2021 Joint Venture Monitoring Equipment
K-MAC BioCenter 01-Jun-2017 Merger/Acquisition Laboratory Services (Healthcare)
To view Sugentech’s complete investments and acquisitions history, request access »

Sugentech ESG

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

Rank

Percentile

Healthcare

Industry

Rank

Percentile

Medical Devices

Subindustry

Rank

Percentile

To view Sugentech’s complete esg history, request access »

Sugentech FAQs

  • When was Sugentech founded?

    Sugentech was founded in 2011.

  • Where is Sugentech headquartered?

    Sugentech is headquartered in Daejeon, South Korea.

  • What is the size of Sugentech?

    Sugentech has 154 total employees.

  • What industry is Sugentech in?

    Sugentech’s primary industry is Diagnostic Equipment.

  • Is Sugentech a private or public company?

    Sugentech is a Public company.

  • What is Sugentech’s stock symbol?

    The ticker symbol for Sugentech is 253840.

  • What is the current stock price of Sugentech?

    As of 18-Nov-2026 the stock price of Sugentech is $2.91.

  • What is the current market cap of Sugentech?

    The current market capitalization of Sugentech is $44.5M.

  • What is Sugentech’s current revenue?

    The trailing twelve month revenue for Sugentech is $6.74M.

  • Who are Sugentech’s competitors?

    Ion Beam Applications, Agenus, Arcus Biosciences, TRACON Pharmaceuticals, and Fate Therapeutics are some of the 15 competitors of Sugentech.

  • What is Sugentech’s annual earnings per share (EPS)?

    Sugentech’s EPS for 12 months was -$1.04.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process